Gardiner Nathaniel S. 4
4 · ENANTA PHARMACEUTICALS INC · Filed Apr 19, 2023
Insider Transaction Report
Form 4
Gardiner Nathaniel S.
Sr. VP & General Counsel
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-04-18−6,667→ 7,000 totalExercise: $30.00Exp: 2026-11-18→ Common Stock (6,667 underlying) - Exercise/Conversion
Common Stock
2023-04-18$30.00/sh+6,667$200,010→ 79,980 total
Holdings
- 28,107(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These shares are held by a grantor retained annuity trust created by the reporting person for the benefit of himself and his two adult children.
- [F2]100% of the shares subject to the option are fully vested and exercisable.